Randomized, double-blind, placebo-controlled immunoprevention trial with MUC1 vaccine in patients with newly diagnosed advanced adenomas

Category Primary study
JournalCANCER RESEARCH
Year 2018
This article has no abstract
Epistemonikos ID: 1fe5fceff5adebab874692383c9ae1055af6b39d
First added on: Feb 01, 2023